2026-2027 Group Meeting Schedule
All meetings will be held on the first Wednesday of the month from 9:00 a.m. – 10:00 a.m. Meetings will be held in room 115 BRT unless otherwise indicated.
Biofilms in Human Medicine Interest Group
The goal of the Biofilms in Human Medicine Interest Group is to define the critical factors that facilitate bacterial biofilm development in human diease and then use this knowledge to develop therapies to prevent initial infection or progression to persistent biofilms. Join us to connect and learn more about biofilms. This group meets once a month and is coordinated by Daniel Wozniak, Ph.D. Professor and Vice Chair, Department of Microbial Infection and Immunity, College of Medicine. See Q&A below followed by the monthly meeting schedule.
Question
Why are biofilms important?
Answer
Biofilms, which are communities of microorganisms that are attached to a surface, play a critical role in numerous infectious diseases. The U.S. Centers for Disease Control (CDC) and National Institutes of Health (NIH) recently estimated that biofilms are responsible for 65% to 80% of all infections. In 2008, the Cellular and Molecular Immunology B Study Section (CMIB) established a multi-disciplinary translational biofilms research group that consists of microbiologists, immunologists, biochemists, pathologists, computational biologists, infectious diseases experts, as well as pulmonary and otolaryngology specialists. The team meets monthly to discuss scientific and programmatic themes with the goal to submit an NIH program project grant.
Question
Which infectious diseases are represented?
Answer
The human diseases represented by the projects include cystic fibrosis, chronic gastrointestinal disease, chronic otisis media and sinustis, dental carries, infection of the genitourinary tract, periodonitis, and device related infection.
Question
Who participates in this group?
Answer
Those participating include scientists and clinicians from OSU (infectious disease, dentistry, oral biology, orthopedics, microbiology, DHLRI, and FAES) as well as Nationwide Children's Hospital and Battelle Memorial Institute.
- October 7, 2026 (Samantha King's Laboratory)
- Location: Room L045, James Conference Center
- November 4, 2026 (Matthew Long's Laboratory)
- December 2, 2026 (Kevin Mason's Laboratory)
- January 6, 2027 (John Gunn's Laboratory)
- February 3, 2027 (Chris Peritore and Angela Kruse)
- March 3, 2027 (Ahmed Aladhami's Laboratory)
- April 7, 2027 (Skye Fishbein's Laboratory)
- May 5, 2027 (Razi Kebriaei's Laboratory)
Biofilms in Human Medicine Interest Group Coordinator
Email
Phone